SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Trading Update

22 Nov 2018 07:00

RNS Number : 1435I
Ebiquity PLC
22 November 2018
Β 

Ebiquity Plc

Β 

Trading Update

Β 

Β 

Ebiquity plc ("Ebiquity"), a leading independent marketing and media consultancy, provides a trading update in relation to the financial year to 31 December 2018.

Β 

At Group level, Ebiquity anticipates organic revenue growth of circa 2%. However, the previously reported slowdown in the Advertising Intelligence practice, coupled with continued underperformance of the US Digital Analytics practice (for which actions have been taken) and delays in closing recent Media practice opportunities in Germany will result in operating profit being materially below current market expectations. With today's announcement of the CMA's final clearance of the sale of the Advertising Intelligence business, the Group's net debt position will be materially improved following the receipt of sale proceeds now anticipated to be around the end of the year.

Β 

Despite the revenue delays in Germany and challenges in the US Digital Analytics practice, the Media, Analytics and Tech practices (being the retained business following the disposal of the Advertising Intelligence business) continue to make strong progress in most territories, with overall revenue growth in line with expectations at circa 8% with particularly encouraging performances in the UK & Ireland and French markets. Encouraging new business wins in H2 include a global multi-year assignment across VW Group and the appointment as a global analytics partner to Nestle. Overall however, at an operating profit level, continued investment in these practices will mean profits are anticipated being below expectations.

Β 

The Advertising Intelligence practice continued to underperform in the year, given the ongoing uncertainties around the proposed disposal. This lengthy process required a considerable amount of management time and attention. The completion of this transaction will simplify the Group allowing it to focus on growing its core Media, Analytics and Tech practices going forward.

Β 

22 November 2018

Enquiries:

Β 

Ebiquity plc

Michael Karg (CEO)

Kevin McNair (Interim CFO)

Β 

020 7650 9600

Β 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7457 2020

Β 

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

Β 

020 7260 1000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTDDBDBIUDBGIB
Date   Source Headline
28th May 20265:04 pmRNSResult of AGM
1st May 20261:15 pmRNSNotice of ARA and AGM
27th Apr 202611:42 amRNSNotification of Major Holdings
21st Apr 20262:35 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSFinal Results
13th Apr 20261:31 pmRNSNotice of Investor Presentation
13th Apr 20261:29 pmRNSNotice of Results
31st Mar 20267:00 amRNSTotal Voting Rights
20th Mar 20264:17 pmRNSTotal Voting Rights
9th Mar 202612:36 pmRNS-REbiquity Appoints Head of Growth, Americas
6th Feb 202610:03 amRNS-REbiquity Strategic Leadership Appointment
22nd Jan 20267:00 amRNSTrading Update
24th Nov 202512:33 pmRNSTR-1: Notification of Major Holdings
21st Oct 20258:00 amRNS-REbiquity Joins Ad Context Protocol
15th Oct 20259:27 amRNSNotification of Major Holdings
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20251:22 pmRNS-RInvestor Presentation
1st Oct 20251:17 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSTrading Update
16th Sep 20257:00 amRNS-RNotice of Investor Presentation
2nd Sep 20257:00 amRNS-RLaunch of Advisory Board to Drive Strategic Growth
1st Sep 20257:00 amRNSBoard Changes
21st Aug 202511:53 amRNSNotification of Major Holdings
6th Aug 20258:30 amRNSTrading Update and Notice of Interim Results
29th Jul 202511:32 amRNSAllotment of Shares and Total Voting Rights
29th Jul 20259:22 amRNSBoard Appointments
24th Jun 20254:03 pmRNS-REbiquity Strengthens Americas Leadership
10th Jun 20257:00 amRNS-RAwarded Silver as a Top UK Media Consultancy
4th Jun 20255:24 pmRNSResult of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
2nd May 202511:59 amRNSAnnual Report and Notice of Annual General Meeting
22nd Apr 20257:00 amRNSFinal Results
10th Apr 20252:41 pmRNSNotice of Results
9th Apr 20257:00 amRNSNotification of major holdings
31st Mar 20254:33 pmRNSTotal Voting Rights
19th Mar 202510:00 amRNSHolding(s) in Company
19th Mar 202510:00 amRNSHolding(s) in Company
12th Mar 202510:46 amRNSIssue of Shares and TVR
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
17th Feb 20257:00 amRNSAppointment of NOMAD and Trading Update
5th Dec 20247:00 amRNSTrading Update
19th Nov 20247:00 amRNSDirectorate Change
3rd Oct 20244:22 pmRNSTotal Voting Rights
30th Sep 20249:27 amRNSNotification of major holdings
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20241:56 pmRNSNotification of major holdings
22nd Aug 202410:55 amRNSTrading Update and Notice of results
22nd Aug 20247:00 amRNSTrading Update and Notice of results
5th Aug 20247:00 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.